Source:http://www.reactome.org/biopax/48887BiochemicalReaction2565
| Predicate | Object |
|---|---|
| rdf:type | |
| biopax3:comment |
Authored: Shamovsky, V, 2012-04-19,
Edited: Shamovsky, V, 2012-05-25,
MAL(TIRAP) undergoes tyrosine phosphorylation mediated by Bruton's tyrosine kinase (BTK). BTK-specific inhibitor, LFM-A13, blocked the phosphorylation of MAL in human HEK293 stimulated with LPS or macrophage-activating lipopeptide-2. LFM-A13 also inhibited activation of NF-kB in LPS-treated human monocytic cell line THP-1 [Gray P et al 2006; Jefferies CA et al 2003]. Tyr-86, Tyr-106 and Tyr-187 were identified as possible phosphorylation sites [Gray P et al 2006]. An additional study has shown that Tyr-86, Tyr-106, and Tyr-159 are important residues, as mutagenesis of these residues impaired MAL phosphorylation, affected its interaction with BTK and also impaired downstream signaling [Piao W et al 2008].,
Reviewed: D'Eustachio, P, 2012-05-25
|
| biopax3:xref | |
| biopax3:dataSource | |
| biopax3:displayName |
MAL is phosphorylated by BTK
|
| biopax3:eCNumber |
2.7.10
|
| biopax3:left | |
| biopax3:right |